Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05574699 · ClinicalTrials.gov registry record · NA
Social Risk Score, Clinical Decision Support Tool and Closed Loop Referral for Social Risk Screen and Referral
A NA study of Hypertension and Diabetes Mellitus, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 251
- Enrollment target
- 5
- Study locations
NCT05574699 is a NA study of Hypertension and Diabetes Mellitus that has completed, run by Johns Hopkins University. The registered enrollment target is 251 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (93% lower). The trial reports 5 study locations across 1 state.
The verdict
NCT05574699, a NA study of Hypertension and Diabetes Mellitus, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 251 participants
- Enrollment target
- 5
- Study locations
Study Summary
The overarching goal of this project is to leverage health information technology (HIT) to integrate available digital information on social needs to improve care for racial and ethnic minorities and socially disadvantaged populations with chronic diseases. In the previous phases of this project the investigators developed a social risk score to identify social needs among medically under-served patients with special emphasis on application among African American patients with low income and chronic diseases who face social determinants, risk factors, and needs (SDRN) challenges. The investigators also developed a clinical decision support (CDS) tool to present the social risk score to clinical providers and sought feedback from different users on the face and content validity of the CDS tool. In the current project the investigators will run a randomized clinical trial (RCT) study to pilot test the new risk score and CDS tool in selected primary care clinics at Johns Hopkins Health System (JHHS) and in collaboration with selected community-based organizations (CBOs). This system will help identify, manage, and refer patients with both high levels of disease burden and modifiable SDRN challenges.
Conditions Studied
Interventions
- OTHER Standard of Care
- OTHER Social Risk Score and CDS Tool
Study Locations (5)
Maryland
- Johns Hopkins GreenSpring Station - Baltimore
- Johns Hopkins Community Physicians - EBMC - Baltimore
- Johns Hopkins Community Physicians - Remington - Baltimore
- Johns Hopkins Bayview Medical Center - Comprehensive Care Practice - Baltimore
- Johns Hopkins JHOC-GIM Clinic - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 251 participants |
| Start Date | 2023-04-30 |
| Est. Completion | 2025-05-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05574699
The ClinicalTrials.gov registry entry for NCT05574699 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 251 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (93% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT05574699 reports 5 study locations spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT05574699 about?
NCT05574699 is a clinical study titled "Social Risk Score, Clinical Decision Support Tool and Closed Loop Referral for Social Risk Screen and Referral". The overarching goal of this project is to leverage health information technology (HIT) to integrate available digital information on social needs to improve care for racial and ethnic minorities and socially disadvantaged populations with chronic diseases. In the previous phases of this project th...
What is the current status of trial NCT05574699?
This trial is currently completed. It is a NA study. The enrollment target is 251 participants. The study started on 2023-04-30. Estimated completion is 2025-05-27.
What conditions does trial NCT05574699 study?
This clinical trial studies the following conditions: Hypertension, Diabetes Mellitus, Congestive Heart Failure, Chronic Disease.
What interventions are being tested in trial NCT05574699?
The interventions under investigation include: Standard of Care (OTHER), Social Risk Score and CDS Tool (OTHER).
Who is sponsoring clinical trial NCT05574699?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05574699 being conducted?
This trial has 5 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.